SteelPeak Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,484	Closed	-$590K	–	578
2025 Q4	$590K	Sell	1,484 -151	-9%	-$66.8K	0.02%	333
2025 Q3	$745K	Sell	1,635 -1,173	-42%	-$478K	0.03%	339
2025 Q2	$916K	Buy	2,808 +81	+3%	+$22.4K	0.04%	274
2025 Q1	$736K	Sell	2,727 -753	-22%	-$194K	0.03%	297
2024 Q4	$819K	Buy	3,480 +1,005	+41%	+$264K	0.03%	276
2024 Q3	$681K	Sell	2,475 -1,071	-30%	-$279K	0.03%	271
2024 Q2	$862K	Sell	3,546 -3,314	-48%	-$523K	0.04%	244
2024 Q1	$1.03M	Buy	6,860 +4,090	+148%	+$682K	0.05%	214
2023 Q4	$530K	Sell	2,770 -1,655	-37%	-$282K	0.03%	272
2023 Q3	$784K	Buy	4,425 +1,408	+47%	+$269K	0.05%	206
2023 Q2	$573K	Buy	3,017 +322	+12%	+$63.8K	0.03%	231
2023 Q1	$540K	Buy	2,695 +276	+11%	+$58K	0.04%	231
2022 Q4	$575K	Sell	2,419 -1,047	-30%	-$223K	0.04%	225
2022 Q3	$694K	Buy	3,466 +9	+0.3%	+$1.72K	0.05%	199
2022 Q2	$504K	Buy	+3,457	New	+$490K	0.04%	250